Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong

Linda L. D.  Zhong; Wai Kun; Nannan Shi; Tat Chi Ziea; Bacon F. L.  Ng; Ying Gao; Zhaoxiang  Bian; Aiping Lu

doi:10.1186/s13020-020-00397-9

Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong

Linda L. D. Zhong^*, Wai Kun, Nannan Shi, Tat Chi Ziea, Bacon F. L. Ng, Ying Gao, Zhaoxiang Bian, Aiping Lu^*

^*Corresponding author for this work

Research output: Contribution to journal › Journal article › peer-review

11 Citations (Scopus)

Abstract

Background

Stroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies.

Methods

Based on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts.

Results

In this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care.

Conclusion

The target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.

Original language	English
Article number	116
Number of pages	7
Journal	Chinese Medicine
Volume	15
DOIs	https://doi.org/10.1186/s13020-020-00397-9
Publication status	Published - Dec 2020

Scopus Subject Areas

Pharmacology
Complementary and alternative medicine

User-Defined Keywords

Acupuncture
Chinese medicine
Clinical practice guideline
Evidence-based medicine
Stroke

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1186/s13020-020-00397-9

Cite this

@article{31d108e5da874acc812b378258a5fd7c,

title = "Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong",

abstract = "BackgroundStroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. MethodsBased on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. ResultsIn this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. ConclusionThe target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.",

keywords = "Acupuncture, Chinese medicine, Clinical practice guideline, Evidence-based medicine, Stroke",

author = "Zhong, {Linda L. D.} and Wai Kun and Nannan Shi and Ziea, {Tat Chi} and Ng, {Bacon F. L.} and Ying Gao and Zhaoxiang Bian and Aiping Lu",

note = "Funding Information: The research was financially funded by Hong Kong Hospital Authority Research Project: Chinese Medicine Clinical Practice Guideline in Stroke, Insomnia and Chronic Gastritis (HA820/126/19/19/14/6/12/1). Publisher copyright: {\textcopyright} The Author(s) 2020.",

year = "2020",

month = dec,

doi = "10.1186/s13020-020-00397-9",

language = "English",

volume = "15",

journal = "Chinese Medicine",

issn = "1749-8546",

publisher = "BioMed Central Ltd.",

}

TY - JOUR

T1 - Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong

AU - Zhong, Linda L. D.

AU - Kun, Wai

AU - Shi, Nannan

AU - Ziea, Tat Chi

AU - Ng, Bacon F. L.

AU - Gao, Ying

AU - Bian, Zhaoxiang

AU - Lu, Aiping

N1 - Funding Information: The research was financially funded by Hong Kong Hospital Authority Research Project: Chinese Medicine Clinical Practice Guideline in Stroke, Insomnia and Chronic Gastritis (HA820/126/19/19/14/6/12/1). Publisher copyright: © The Author(s) 2020.

PY - 2020/12

Y1 - 2020/12

N2 - BackgroundStroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. MethodsBased on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. ResultsIn this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. ConclusionThe target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.

AB - BackgroundStroke in Chinese Medicine (CM) includes the concepts of ischemic and hemorrhagic strokes from Western Medicine and is a common disease in Hong Kong. This clinical practice guideline (CPG) aims to evaluate and demonstrate CM treatment options for stroke, provide guideline for local CM practice, and act as a reference for decision makers on drafting CM related health policies. MethodsBased on the principle of multidisciplinary integration and evidence-based medicine, a steering committee oversaw the CPG development process in accordance with a published protocol. Clinical questions and evidences were identified, appraised, and synthesised through systematic literature reviews, text mining, and two rounds of Delphi surveys with a multidisciplinary panel of experts. ResultsIn this CPG, we defined stroke from the perspectives of both CM and Western Medicine, reported corresponding CM treatment options, and carried out evaluation based on levels of evidence and grade of recommendation. Suggested CM interventions include herbal medicine treatment based on pattern differentiation, acupuncture treatment, and nursing care. ConclusionThe target population is Hong Kong stroke patients with prodrome or sequela stage. This CPG is intended to help standardizing CM clinical practice and enhancing efficiency of clinical service in Hong Kong.

KW - Acupuncture

KW - Chinese medicine

KW - Clinical practice guideline

KW - Evidence-based medicine

KW - Stroke

UR - http://www.scopus.com/inward/record.url?scp=85094928554&partnerID=8YFLogxK

U2 - 10.1186/s13020-020-00397-9

DO - 10.1186/s13020-020-00397-9

M3 - Journal article

AN - SCOPUS:85094928554

SN - 1749-8546

VL - 15

JO - Chinese Medicine

JF - Chinese Medicine

M1 - 116

ER -

Evidence-based Chinese Medicine Clinical Practice Guideline for Stroke in Hong Kong

Abstract

Scopus Subject Areas

User-Defined Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this